Pharma and biotech customers distinguish excellence in capabilities, expertise, quality, compatibility, reliability and service
Waltham, Mass. (March 3, 2022) – For the third consecutive year, Thermo Fisher Scientific’s pharma and biopharma customers recognized its contract manufacturing leadership in all six categories of the 11th Annual CMO Leadership awards.
The annual honors, presented by Life Science Leader and Outsourced Pharma, spotlight excellence in Capabilities, Expertise, Quality, Compatibility, Reliability and Service. The customers evaluated 86 companies across 23 performance metrics.
"Patients worldwide need treatments sooner than ever so we need to exceed our customers’ expectations every day,” said Mike Shafer, senior vice president and president, pharma services, Thermo Fisher Scientific. “We’re grateful that the innovators we serve value the progress we’re making toward that goal.”
This is Thermo Fisher’s ninth straight year being recognized by the CMO Leadership Awards, which distinguish top contract manufacturing organizations each year by surveying leading global pharma and biotech companies. That research, based on the Contract Manufacturing Quality Benchmarking conducted by Industry Standard Research (ISR), involved customers of all sizes that worked with the organizations during the past 18 months.
“For nearly a decade, the CMO Leadership Awards have recognized our industry’s top service providers – CDMOs that have remained steadfast partners to pharma and biopharma companies,” said Louis Garguilo, Chief Editor, Outsourced Pharma. “These awards have proven most meaningful for biopharma organizations striving to obtain optimal outcomes from their outsourcing activities. Our research arm, Industry Standard Research (ISR), which only surveys drug sponsors who have worked recently with specific CDMOs, ensures the validity of these results.”
To learn more about the CMO Leadership Awards, please visit https://www.cmoleadershipawards.com/.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Now in its 11th year, Outsourced Pharma and Life Science Leader's CMO Leadership Awards provide readers with accurate and reliable customer feedback to assist them in choosing a reputable partner for their development and manufacturing needs. For the 2022 CMO Leadership Awards, Industry Standard Research (ISR) determined the award recipients through their evaluation of more than 86 contract manufacturers. These CMOs were assessed by 23 performance metrics in ISR's annual Contract Manufacturing Quality Benchmarking survey. For more information about the awards, visit the awards website.
Media Contact Information:
Thermo Fisher Scientific
SOURCE Thermo Fisher Scientific
If you have any questions regarding this Press Release, please email us at firstname.lastname@example.org.